Over 95% of PV, ET, and PMF are associated with mutually exclusive somatic driver mutations JAK2V617F, calreticulin (CALR), and myeloproliferative leukemia protein (MPL) [9,10,11,12,13]. This evidence concerns the gene CALR and essential thrombocythemia.